CyberKnife® is the world's first and only robotic stereotactic radiosurgery system available with FDA approval. CyberKnife technology utilizes highly sophisticated robotics to target and destroy previously inaccessible tumors or lesions anywhere in the body.
CyberKnife has proven to be an effective alternative to surgery or conventional radiation therapy for treating with sub-millimeter accuracy vascular abnormalities, tumors, functional disorders, and cancers imbedded deep within the body. CyberKnife offers patients a better quality of life, especially those patients with tumors previously diagnosed as 'inoperable,' or for those who have already received the maximum amount of radiation through other treatment methods.